AVXS-101 (OAV101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVXS-101 (OAV101), covering 2024-01-05 to 2024-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) [Phase 3]